US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Trust NYSE Arca Biotechnology Index Fund

268.15

-3.0800-1.14%

Post-market: 268.150.00000.00%19:30 EDT

Volume:23.51K

Turnover:6.32M

Market Cap:2.91B

PE:31.38

High:271.63

Open:271.63

Low:267.73

Close:271.23

52wk High:274.99

52wk Low:173.98

Shares:10.85M

Float Shares:10.85M

Volume Ratio:0.78

T/O Rate:0.22%

Dividend:- -

Dividend Rate:- -

EPS(TTM):8.55

EPS(LYR):37.75

ROE:19.96%

ROA:-0.16%

PB:1.04

PE(LYR):7.10

Loading ...

Overview Company News Filings

Patrys flags investment risks and uncertainty around therapeutic drug development

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Celldex (CLDX)

Bruker to Release Q2 2026 Results, Host Earnings Webcast and Conference Call

Neogenomics is Maintained at Buy by Benchmark

AI Power Demand Reshapes Energy Investments, Brookfield Asset Management Acquires Storage Leader Aypa for $7 Billion

Corcept Therapeutics to Announce Second Quarter Financial Results

Corcept Therapeutics Schedules Second-quarter Results Conference Call

How DOJ Settlement Resolution and New PTEN CDx Launch Will Impact NeoGenomics (NEO) Investors

Simply Wall St.

Alkermes Plc : Leerink Partners Raises Target Price to $50 from $34

THOMSON REUTERS

Neogenomics to Pay $9.8M to Resolve Allegations of False Claims Act Violation

NeoGenomics Resolves DOJ Investigation, Refocuses on Cancer Care

Neogenomics Settlement Comes in Under Accrued Reserves

Neogenomics Resolves DOJ Investigation

NeoGenomics announces settlement of voluntary disclosure to OIG-HHS

Neogenomics Agrees to Pay USD 9.81 Million to Settle DOJ Probe Tied to Lab Collaboration Program

Neogenomics - to Pay $9.81 Mln Plus 4.25% Interest from Jan 16, 2026 to Resolve Matter

THOMSON REUTERS

Neogenomics - Finalizes Civil Settlement with DOJ and Oig Resolving Investigation

THOMSON REUTERS

Neogenomics Announces Settlement of Voluntary Disclosure to Oig-hhs

THOMSON REUTERS

Alkermes Plc : Stifel Raises Target Price to $63 from $45

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY) and Alkermes (ALKS)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/FBT/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"FBT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBT\",,,,,undefined,":{"symbol":"FBT","market":"US","secType":"STK","nameCN":"First Trust NYSE Arca Biotechnology Index Fund","latestPrice":268.15,"timestamp":1789761600000,"preClose":271.23,"halted":0,"volume":23507,"hourTrading":{"tag":"盘后","latestPrice":268.15,"preClose":268.15,"latestTime":"19:30 EDT","volume":17,"amount":4553.29,"timestamp":1789774206683,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.011355675994543526,"floatShares":10850002,"shares":10850002,"eps":8.545272,"marketStatus":"Market Closed","change":-3.08,"latestTime":"09-18 16:00:00 EDT","open":271.63,"high":271.63,"low":267.73,"amount":6319864.942380001,"amplitude":0.014379,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":8.545272,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":271.23,"sharesOutstanding":11450002,"nav":270.95,"aum":2953355541.9,"bidAskSpread":0.00095,"preHourTrading":{"tag":"盘前","latestPrice":271.23,"preClose":271.23,"latestTime":"07:36 EDT","volume":4,"amount":1084.9316,"timestamp":1789731363239,"change":0,"changeRate":0,"amplitude":0.000043},"postHourTrading":{"tag":"盘后","latestPrice":268.15,"preClose":268.15,"latestTime":"19:30 EDT","volume":17,"amount":4553.29,"timestamp":1789774206683,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7794563330839,"impliedVol":0.2045,"impliedVolPercentile":0.4223},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBT\",,,,,undefined,":{"symbol":"FBT","floatShares":10850002,"roa":"-0.16%","roe":"19.96%","lyrEps":37.754725,"volumeRatio":0.7794563330839,"shares":10850002,"dividePrice":0,"high":271.63,"amplitude":0.014379,"preClose":271.23,"low":267.73,"week52Low":173.975,"pbRate":"1.04","psRate":"701.87","week52High":274.99,"institutionHeld":0,"latestPrice":268.15,"eps":8.545272,"divideRate":0,"volume":23507,"delay":0,"ttmEps":8.545272,"open":271.63,"prevYearClose":206.52,"prevWeekClose":261.85,"prevMonthClose":267.15,"prevQuarterClose":247.89,"fiveDayClose":261.85,"twentyDayClose":268.125,"sixtyDayClose":237.29},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FBT\",params:#limit:5,,,undefined,":[{"date":"2024-12-13","symbol":"FBT","amount":1.1726,"announcedDate":"2024-12-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-13","defaultRemindTime":1734100200000,"name":"First Trust NYSE Arca Biotechnology Index Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-13","currency":"USD","dateTimestamp":1734066000000,"payDate":"2024-12-31"},{"market":"US","date":"2022-01-10","symbol":"FBT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1641790800000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2021-12-30","symbol":"FBT","amount":2.2136,"defaultRemindTime":1640874600000,"name":"First Trust NYSE Arca Biotechnology Index Fund","recordDate":"2022-01-10","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FBT\",market:\"US\",,,undefined,":[{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-10","value":2.2136,"currency":"USD"},{"executeDate":"2024-12-13","recordDate":"2024-12-13","paymentDate":"2024-12-31","value":1.1726,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FBT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FBT\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2654672100","title":"Patrys flags investment risks and uncertainty around therapeutic drug development","url":"https://stock-news.laohu8.com/highlight/detail?id=2654672100","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654672100?lang=en_us&edition=fundamental","pubTime":"2026-07-27 06:51","pubTimestamp":1785106305,"startTime":"0","endTime":"0","summary":"Patrys Limited ( ($AU:PAB) ) has provided an update. Patrys Limited has released a general information presentation outlining its activities in res...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/patrys-flags-investment-risks-and-uncertainty-around-therapeutic-drug-development?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/patrys-flags-investment-risks-and-uncertainty-around-therapeutic-drug-development?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PAB","BMED","LFSC","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654054554","title":"Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Celldex (CLDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2654054554","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654054554?lang=en_us&edition=fundamental","pubTime":"2026-07-25 22:50","pubTimestamp":1784991019,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alkermes (ALKS) and Celldex (CLDX) with bullish sent...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-and-celldex-cldx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-and-celldex-cldx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FBT","BK4581","MEDX","BK4139","HCSG","PSIL","BK4585","LABU","XBI","ALKS","PSCH","IBRN","BK4137","CLDX","LU0128526141.USD","BK4588","XLV","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654032304","title":"Bruker to Release Q2 2026 Results, Host Earnings Webcast and Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2654032304","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654032304?lang=en_us&edition=fundamental","pubTime":"2026-07-25 04:01","pubTimestamp":1784923272,"startTime":"0","endTime":"0","summary":"Bruker to release Q2 2026 results, host earnings webcast and conference callBruker schedules Q2 2026 results release before the market opens on Aug. 4, 2026.Conference call webcast set for Aug. 4, 202","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nNDLpWK38:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","FBT","TINY","LU1815336091.USD","LU0757428866.USD","BRKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653222082","title":"Neogenomics is Maintained at Buy by Benchmark","url":"https://stock-news.laohu8.com/highlight/detail?id=2653222082","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653222082?lang=en_us&edition=fundamental","pubTime":"2026-07-24 20:50","pubTimestamp":1784897400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NEO/analyst-ratings(END) Dow Jones NewswiresJuly 24, 2026 08:50 ET","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4196","LU0106261612.USD","FBT","NEO","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173784170","title":"AI Power Demand Reshapes Energy Investments, Brookfield Asset Management Acquires Storage Leader Aypa for $7 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1173784170","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173784170?lang=en_us&edition=fundamental","pubTime":"2026-07-23 08:14","pubTimestamp":1784765669,"startTime":"0","endTime":"0","summary":"Brookfield Asset Management Ltd (NYSE: BAM) has agreed to acquire battery storage developer Aypa Power for $7 billion, including debt. This move comes as demand surges from companies fueling the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTY","HEAT","QTOC","02570","BK1171","VTHR","ANEW","BAM","BRKR","TINY","AGIX","LU0757428866.USD","CHAT","LU1815336091.USD","ACES","BK4135","FBT","BK4121","BK4585","AIPO","BK4588","PBW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653799128","title":"Corcept Therapeutics to Announce Second Quarter Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2653799128","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653799128?lang=en_us&edition=fundamental","pubTime":"2026-07-23 06:00","pubTimestamp":1784757602,"startTime":"0","endTime":"0","summary":"BRIEF-Corcept Therapeutics To Announce Second Quarter Financial ResultsJuly 22 (Reuters)-Corcept Therapeutics IncCORT.O:CORCEPT THERAPEUTICS TO ANNOUNCE SECOND QUARTER FINANCIAL RESULTS, PROVIDE CORPORATE UPDATE AND HOST CONFERENCE CALLSource text:ID:nBw7GQVldaFurther company coverage:CORT.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nTUA2QJWLY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU1559883803.SGD","BK4532","FBT","CORT","LU0566484027.USD","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653798193","title":"Corcept Therapeutics Schedules Second-quarter Results Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2653798193","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653798193?lang=en_us&edition=fundamental","pubTime":"2026-07-23 04:05","pubTimestamp":1784750729,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics schedules second-quarter results conference callCorcept set July 29, 2026 to report second-quarter financial results, issue a corporate update, host a conference call at 5 p.m. ET","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDL1V8Pdx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","FBT","CORT","BK4007","PSCH","LU0566484027.USD","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653013712","title":"How DOJ Settlement Resolution and New PTEN CDx Launch Will Impact NeoGenomics (NEO) Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2653013712","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653013712?lang=en_us&edition=fundamental","pubTime":"2026-07-21 22:27","pubTimestamp":1784644055,"startTime":"0","endTime":"0","summary":"In June 2026, NeoGenomics finalized a civil settlement with the U.S. Department of Justice, agreeing to pay US$9,813,260 plus interest to resolve an investigation into consulting arrangements, having previously reserved US$11,200,000 for potential liabilities.\nSeparately, the company launched PTEN IHC CDx, the first FDA-approved immunohistochemistry companion diagnostic for PTEN-deficient prostate adenocarcinoma, expanding its role in targeted prostate cancer care.\nWe’ll now examine how...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-neo/neogenomics/news/how-doj-settlement-resolution-and-new-pten-cdx-launch-will-i","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-neo/neogenomics/news/how-doj-settlement-resolution-and-new-pten-cdx-launch-will-i","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4211","LU0012050646.USD","NEO","LU0106261612.USD","FBT","BK4092","ISBC","BK4121","BK4196","PTEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653277231","title":"Alkermes Plc : Leerink Partners Raises Target Price to $50 from $34","url":"https://stock-news.laohu8.com/highlight/detail?id=2653277231","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653277231?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:34","pubTimestamp":1784637260,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nFWN43N0YI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","MEDX","ALKS","PSCH","PSIL","BK4139","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653249601","title":"Neogenomics to Pay $9.8M to Resolve Allegations of False Claims Act Violation","url":"https://stock-news.laohu8.com/highlight/detail?id=2653249601","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653249601?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:59","pubTimestamp":1784584740,"startTime":"0","endTime":"0","summary":"NeoGenomics agreed to pay $9.8 million to resolve allegations that it violated the False Claims Act.The Justice Department alleged that the cancer diagnostics company provided laboratory consulting se","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Neogenomics to Pay $9.8M to Resolve Allegations of False Claims Act Violation","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","NEO","BK4121","LU0106261612.USD","BK4196","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653494062","title":"NeoGenomics Resolves DOJ Investigation, Refocuses on Cancer Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2653494062","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653494062?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:47","pubTimestamp":1784584059,"startTime":"0","endTime":"0","summary":"NeoGenomics ( ($NEO) ) just unveiled an update. On June 20, 2026, NeoGenomics finalized a civil settlement with the U.S. Department of Justice, act...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neogenomics-resolves-doj-investigation-refocuses-on-cancer-care?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neogenomics-resolves-doj-investigation-refocuses-on-cancer-care?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","BK4121","FBT","LU0012050646.USD","LU0106261612.USD","NEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653249572","title":"Neogenomics Settlement Comes in Under Accrued Reserves","url":"https://stock-news.laohu8.com/highlight/detail?id=2653249572","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653249572?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:46","pubTimestamp":1784583960,"startTime":"0","endTime":"0","summary":"NeoGenomics finalized a civil settlement with the Department of Justice, resolving an investigation into consulting services the company provided to health care providers through its Laboratory Collaboration Initiative. The settlement of $9.8 million, plus interest at a rate of 4.25%, falls below the $11.2 million in reserves the company previously disclosed in SEC filings. NeoGenomics is set to report second-quarter results on July 28.This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors. Dow Jones NewswiresJuly 20, 2026 17:46 ET Copyright  2026 Dow Jones & Company, Inc.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4196","LU0106261612.USD","FBT","NEO","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653249504","title":"Neogenomics Resolves DOJ Investigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2653249504","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653249504?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:46","pubTimestamp":1784583960,"startTime":"0","endTime":"0","summary":"The $9.8 million settlement NeoGenomics reached with the DOJ traces back to a voluntary disclosure the company made to the Office of Inspector General of the U.S. Department of Health and Human Services in Nov. 2021. The investigation centered on consulting services tied to laboratory testing under the company's Laboratory Collaboration Initiative program. The DOJ acknowledged in the settlement agreement that NeoGenomics cooperated with the government's investigation. The agreement isn't an admission of liability by the company nor a concession by the government that its claims lacked merit.This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors. Dow Jones NewswiresJuly 20, 2026 17:46 ET Copyright  2026 Dow Jones & Company, Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","LU0012050646.USD","BK4196","NEO","LU0106261612.USD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653249533","title":"NeoGenomics announces settlement of voluntary disclosure to OIG-HHS","url":"https://stock-news.laohu8.com/highlight/detail?id=2653249533","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653249533?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:30","pubTimestamp":1784583016,"startTime":"0","endTime":"0","summary":"NeoGenomics (NEO) has finalized a civil settlement with the Department of Justice, or DOJ, on behalf of the Office of Inspector General of the U.S....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neogenomics-announces-settlement-of-voluntary-disclosure-to-oig-hhs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neogenomics-announces-settlement-of-voluntary-disclosure-to-oig-hhs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4129","OIG","BK4121","LU0106261612.USD","BK4196","FBT","BK4009","NEO","HHS","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653124607","title":"Neogenomics Agrees to Pay USD 9.81 Million to Settle DOJ Probe Tied to Lab Collaboration Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2653124607","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653124607?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:23","pubTimestamp":1784582611,"startTime":"0","endTime":"0","summary":"NeoGenomics agrees to pay USD 9.81 million to settle DOJ probe tied to lab collaboration programNeoGenomics reached a civil settlement with the U.S. Department of Justice on behalf of OIG-HHS, resolvi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nNDL1SxqG8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEO","LU0012050646.USD","BK4121","LU0106261612.USD","BK4196","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653460202","title":"Neogenomics - to Pay $9.81 Mln Plus 4.25% Interest from Jan 16, 2026 to Resolve Matter","url":"https://stock-news.laohu8.com/highlight/detail?id=2653460202","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653460202?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:23","pubTimestamp":1784582580,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nTUA4GJSKW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0012050646.USD","LU0106261612.USD","NEO","BK4121","BK4196","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653246073","title":"Neogenomics - Finalizes Civil Settlement with DOJ and Oig Resolving Investigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2653246073","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653246073?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:23","pubTimestamp":1784582580,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nTUA4GJSKW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","LU0106261612.USD","BK4121","LU0012050646.USD","NEO","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653246022","title":"Neogenomics Announces Settlement of Voluntary Disclosure to Oig-hhs","url":"https://stock-news.laohu8.com/highlight/detail?id=2653246022","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653246022?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:23","pubTimestamp":1784582580,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nTUA4GJSKW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0012050646.USD","BK4121","LU0106261612.USD","NEO","BK4196","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652290391","title":"Alkermes Plc : Stifel Raises Target Price to $63 from $45","url":"https://stock-news.laohu8.com/highlight/detail?id=2652290391","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652290391?lang=en_us&edition=fundamental","pubTime":"2026-07-20 19:09","pubTimestamp":1784545792,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nFWN43M0KM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSCH","ALKS","PSIL","FBT","BK4139","MEDX","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652329784","title":"Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY) and Alkermes (ALKS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2652329784","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652329784?lang=en_us&edition=fundamental","pubTime":"2026-07-20 18:30","pubTimestamp":1784543447,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Harmony Biosciences Holdings (HRMY) and Alkermes (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-harmony-biosciences-holdings-hrmy-and-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-harmony-biosciences-holdings-hrmy-and-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","PSCH","LU0128526141.USD","IBRN","BK4007","HCSG","BK4588","XLV","BK4139","LABU","MEDX","XBI","PSIL","ALKS","BK4585","FBT","BK4581","LU0029874061.USD","HRMY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}